POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PMR patients: drug may cut steroid dependence
Disease control OngoingThis study tests whether rituximab, a drug that calms the immune system, can help people with polymyalgia rheumatica (PMR) stop or reduce steroid use during a relapse. About 174 adults with PMR who cannot lower their steroid dose below 5 mg per day will receive either rituximab o…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC
-
New imaging methods aim to pinpoint painful muscle disease
Diagnosis OngoingThis study explores whether ultrasound and PET/CT scans can more accurately diagnose and track polymyalgia rheumatica (PMR), a condition causing muscle pain and stiffness. Researchers will follow 98 adults over age 50 suspected of having PMR, using imaging at key points during st…
Matched conditions: POLYMYALGIA RHEUMATICA
Sponsor: Kresten Krarup Keller • Aim: Diagnosis
Last updated Apr 28, 2026 23:50 UTC